skip to main content

Lowenstein Sandler LLP | The contents of this website contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.

Search
Smart Search Icon
Header Search

Recent Searches

Clear all Searches

Relevant Insights

Featured Content

view all search results
Search Close
Hamburger
profile Icon for Mobile

Karen R. Abraham

Senior Counsel
Deputy Chair, Derivatives & Structured Products

New York
T: +1 646.414.6978 F: +1 973.422.6839 kabraham@lowenstein.com
  • BIO
  • EXPERIENCE
  • NEWS & INSIGHTS

See more section

Karen Abraham has extensive experience representing hedge funds and private equity funds in the negotiation and documentation of prime broker, tri-party control and complex over-the-counter trading agreements, including, but not limited to ISDA Master Agreements, Global Master Repurchase Agreements, Master Repurchase Agreements, master confirmation agreements and cryptocurrency purchase and loan agreements. She regularly advises clients with respect to regulatory issues related to derivatives, including compliance with the Dodd-Frank Act, European market infrastructure regulation (EMIR) and other regulatory reforms.

  • Obtained a groundbreaking patent that is listed in the FDA Orange Book for a tamper-resistant formulation of an FDA-approved narcotic analgesic.

Education

  • Columbia Business School (M.B.A. 2007)

    New York Law School (J.D. 2003)

    Sarah Lawrence College (B.A. 1999)

Admissions

  • New York

Related Areas

Subscribe